Mgo One Seven LLC Amgen Inc Transaction History

Mgo One Seven LLC

$2.26 Billion
Q3 2024

A detailed history of Mgo One Seven LLC transactions in Amgen Inc stock. As of the latest transaction made, Mgo One Seven LLC holds 6,851 shares of AMGN stock, worth $1.81 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

6,851

Previous 7,113 3.68%

Holding current value

$1.81 Million

Previous $2.22 Million 0.68%

% of portfolio

0.1%

Previous 0.11%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$309.38 - $337.38 $81,057 - $88,393	-262 Reduced 3.68%	6,851 $2.21 Million
Q2 2024 Aug 07, 2024	BUY	$262.75 - $319.31 $278,777 - $338,787	1,061 Added 17.53%	7,113 $2.22 Million
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $83,618 - $100,938	-311 Reduced 4.89%	6,052 $1.72 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $68,527 - $77,307	268 Added 4.4%	6,363 $1.83 Million
Q3 2023 Nov 03, 2023	BUY	$218.65 - $271.46 $208,592 - $258,972	954 Added 18.56%	6,095 $1.64 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $1.67 Million - $1.98 Million	-7,799 Reduced 60.27%	5,141 $1.14 Million
Q1 2023 May 08, 2023	BUY	$225.79 - $275.2 $1.48 Million - $1.81 Million	6,570 Added 103.14%	12,940 $3.13 Million
Q4 2022 Jan 25, 2023	BUY	$229.03 - $291.01 $341,941 - $434,477	1,493 Added 30.61%	6,370 $0
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $348,810 - $393,395	1,554 Added 46.76%	4,877 $13.9 Million
Q2 2022 Aug 10, 2022	BUY	$230.71 - $256.74 $176,723 - $196,662	766 Added 29.96%	3,323 $809,000
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $32,232 - $35,657	147 Added 6.1%	2,557 $618,000
Q4 2021 Feb 09, 2022	BUY	$198.88 - $227.6 $202,857 - $232,152	1,020 Added 73.38%	2,410 $542,000
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $410,317 - $480,737	-1,933 Reduced 58.17%	1,390 $288,000
Q2 2021 Jul 29, 2021	SELL	$233.58 - $259.14 $48,584 - $53,901	-208 Reduced 5.89%	3,323 $810,000
Q1 2021 Apr 29, 2021	BUY	$221.91 - $258.6 $102,966 - $119,990	464 Added 15.13%	3,531 $878,000
Q4 2020 Jan 22, 2021	SELL	$216.38 - $257.67 $32,673 - $38,908	-151 Reduced 4.69%	3,067 $705,000
Q3 2020 Oct 30, 2020	BUY	$234.65 - $260.95 $19,006 - $21,136	81 Added 2.58%	3,218 $818,000
Q2 2020 Aug 12, 2020	BUY	$197.81 - $242.74 $158,050 - $193,949	799 Added 34.17%	3,137 $740,000
Q1 2020 Apr 17, 2020	BUY	$182.24 - $241.7 $103,876 - $137,769	570 Added 32.24%	2,338 $473,000
Q4 2019 Jan 16, 2020	SELL	$189.21 - $243.2 $6,433 - $8,268	-34 Reduced 1.89%	1,768 $426,000
Q3 2019 Oct 10, 2019	SELL	$174.11 - $208.62 $696 - $834	-4 Reduced 0.22%	1,802 $349,000
Q2 2019 Jul 16, 2019	SELL	$166.7 - $195.41 $22,504 - $26,380	-135 Reduced 6.96%	1,806 $332,000
Q1 2019 Apr 09, 2019	BUY	$180.87 - $203.88 $15,012 - $16,922	83 Added 4.47%	1,941 $368,000
Q4 2018 Jan 24, 2019	SELL	$178.4 - $208.25 $892 - $1,041	-5 Reduced 0.27%	1,858 $361,000
Q3 2018 Oct 09, 2018	BUY	$185.29 - $208.89 $34,278 - $38,644	185 Added 11.03%	1,863 $386,000
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $88,950 - $103,950	525 Added 45.53%	1,678 $286,000
Q4 2017 Feb 16, 2018	BUY	$168.79 - $188.59 $194,614 - $217,444	1,153	1,153 $201,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mgo One Seven LLC with notifications on news.

Account